The Importance of USP 800 in Pharmaceutical Packaging: What You Need to Know

When healthcare personnel handle medications that can cause cancer, birth defects, or organ damage, the packaging around those drugs becomes a frontline safety tool. That is the world USP 800 was built for. For pharmaceutical compounding operations, hospital pharmacies, and repackagers, compliance is not optional, and the packaging systems you choose play a direct role in whether your facility meets the standard. Solutions from Medical Packaging Inc., LLC (MPI) are designed to support safe handling of hazardous drugs while keeping workflows fast, accurate, and traceable.

What is USP 800?

USP 800 is a set of national quality standards for the safe handling of hazardous drugs in any healthcare setting.

Issued by the United States Pharmacopeia and informed by the National Institute for Occupational Safety and Health, USP General Chapter <800> applies to all healthcare workers who come into contact with hazardous drugs and every health care setting where those drugs are handled. The general chapter became compendially applicable on November 1, 2023, alongside revisions to USP 795 (non-sterile preparations) and USP 797 (sterile preparations).

USP 800 sets compounding standards and safety measures across the full hazardous drug lifecycle:

• Receiving: Inspecting and unpacking shipments safely
• Storage: Containment and segregation of hazardous inventory
• Sterile compounding and non-sterile compounding: Use of a containment primary engineering control inside a containment secondary engineering control
• Dispensing and labeling: Accurate identification of every dosage form
• Drug administration: Protecting nurses and patients during delivery
• Disposal and spills: Environmental protection and decontamination protocols

For pharmaceutical packaging systems, the impact is direct. Containment, labeling, traceability, and protection from contamination are documented expectations tied to patient safety and occupational safety.

Why USP 800 Compliance Matters

Non-compliance puts every staff member, patient, and facility at serious risk, both medically and legally.

The Centers for Disease Control and Prevention estimates that roughly 8 million U.S. health care personnel face occupational exposure to hazardous drugs each year. Even trace risk of exposure has been linked to:

• Reproductive risk and developmental issues
• Organ toxicity at low doses
• Increased cancer risk over time
• Genotoxic effects

USP 800 compliance is enforced through state boards of pharmacy, accreditation bodies like The Joint Commission, the FDA, and OSHA. Non-compliance can lead to fines, citations, lost accreditation, and reputational damage. Every health system, cancer center, oncology practice, and individual user handling hazardous drugs is expected to follow the standard.

Compliant packaging systems are a critical line of defense. They reduce open handling, contain contamination at the dosage form level, and create a documented chain of identification from packaging through drug administration.

USP 800 and Pharmaceutical Packaging Systems

The right packaging equipment reduces hands-on contact with hazardous drugs and improves accuracy at every step.

USP 800 emphasizes engineering controls, containment, work practices, and accurate identification. A primary engineering control such as a biosafety cabinet operates under negative pressure inside a clean room or compounding suite to contain hazardous vapors and aerosols. Packaging equipment extends those safety standards downstream by minimizing manipulation of bulk hazardous drugs and producing fully sealed, clearly labeled unit doses.

Oral Solid and Liquid Packaging

MPI’s unit dose systems reduce the manual touchpoints that introduce contamination risk and dosing errors:

• Auto-Print® packages oral solid dosage forms such as tablets and capsules into individually sealed and labeled unit dose containers
• Fluidose® Series 6 handles oral liquids with sealed, labeled color-coded cups in 7ml, 15ml, 25ml, and 35ml sizes
• MPI-certified consumables including SUPERTHERM® thermal paper, SUPERCEL® film, and SUPERFOIL® meet FDA and USP standards for pharmaceutical packaging
• Class A and Class B packaging materials are available depending on medication sensitivity and risk assessment

Overwrapping and Accessory Packaging

Secondary packaging adds another layer of containment that supports clean room protocols and reduces contamination during transport and storage:

• Pharmacy Accessory Bagging System (PABS) provides labeled overwrapping bags
• Auto-Wrap applies labels to filled syringes and vials for specialty applications
• Pharmacy Accessory Label Printers (PALP) produce thermal transfer labels for accessory packaging needs

Labeling and Barcode Traceability

Accurate labeling is one of the most frequently cited compliance issues in pharmacy inspections. MPI’s automated labeling ensures every unit dose carries scannable medication information, expiration dates, lot numbers, and any internal hazardous drug warnings required under the handling of hazardous drugs standards.

Pak-EDGE® UD Barcode Labeling Software ties the system together:

• Generates all linear, 2D, and GS1 barcodes
• Integrates with First Databank for drug data accuracy
• Runs across MPI’s full equipment line through one interface
• Supports bedside scanning and the audit trail USP 800 compliance requires

MPI's Role in Supporting USP 800 Compliance

MPI builds packaging systems specifically for the accuracy, traceability, and material quality that USP 800 demands.

Medical Packaging Inc., LLC has been manufacturing unit-dose packaging and labeling systems since 1971. The portfolio is engineered to help facilities meet FDA, USP, and CMS quality standards across a wide range of health care settings:

• Hospital and acute care pharmacies
• Long-term care and extended care facilities
• Independent and retail pharmacies
• Specialty pharmaceutical manufacturers and CDMOs
• Pharmaceutical repackagers 

MPI also maintains documentation infrastructure that supports regulatory submissions, including a Type III Drug Master File that customers can reference during their own FDA approval processes. In practical terms, every facility staff member using MPI equipment can complete unit dose packaging knowing their material specifications, barcode accuracy, and workflow consistency align with USP 800 and adjacent best practice standards.

Challenges in Achieving USP 800 Compliance

Most compliance failures come from manual processes, inconsistent labeling, and equipment that does not fit existing workflows.

Common pain points include:

• Manual repackaging errors: Transcription mistakes and increased hands-on contact with hazardous drugs
• Unscannable barcodes: Outdated labeling that disrupts bedside verification
• Disconnected systems: Separate databases for drug data, barcoding, and inventory
• Workflow disruption: Difficulty introducing new equipment without slowing daily operations
• Documentation gaps: Inability to produce audit-ready records during inspections of pharmaceutical compounding activities

MPI’s solutions address these friction points directly:

• Automation reduces manual steps and labor costs while supporting personal protective equipment protocols upstream
• Pak-EDGE® centralizes labeling data and cuts duplicate entry
• Stainless steel options are available for clean room and compounding environments
• Pumping parameters and product settings store in software and sync across the system
• Color-coded materials assist with expiration date and controlled medication identification

The Future of USP 800 Compliance in Pharmaceutical Packaging

Compliance is moving toward more automation, better data, and tighter integration between packaging and the rest of the pharmacy.

Several trends are shaping the next phase of hazardous drug handling:

• Updated NIOSH List of Hazardous Drugs in Healthcare Settings was published in December 2024
• Ongoing USP 795 and 797 revisions continue to clarify facility design and engineering controls expectations
• Environmental monitoring requirements are expanding across compounding facilities
• Barcode and traceability standards are tightening alongside electronic health record integration
• Risk assessment documentation is taking on a larger role during inspections

MPI continues to develop equipment, software, and consumables that meet this evolving environment. The combination of unit dose packaging, advanced barcode capability through Pak-EDGE®, and FDA-registered materials gives every health system a foundation to build on as regulatory standards continue to advance.

Strengthening Compliance Through Smarter Packaging Systems

USP 800 sets the standard for protecting healthcare workers, patients, and the environment from the risks of hazardous drug exposure, and pharmaceutical packaging systems are central to meeting that standard. Choosing the right equipment is not just a compliance decision. It is a patient safety decision, an occupational safety decision, and an operational efficiency decision.

Medical Packaging Inc., LLC offers a complete portfolio of unit-dose packaging, labeling, and overwrapping systems built with USP 800 and adjacent compounding standards in mind. To learn how MPI can support compliance and streamline your packaging workflow, contact the MPI team to discuss the right solution for your facility.